Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

1040 Results

View

Closed

Phase

Accrual

63%

Published

SWOG Clinical Trial Number

SWOG-8915

Study of 6-Thioguanine Administered as 120 Hour Continuous Infusion for Refractory or Recurrent Small Cell Lung Carcinoma

Activated

03-01-1990

Closed

12-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8940

A Phase I Study of the Combination of Recombinant Human Interleukin 1-Beta, Etoposide, and Carboplatin in Patients with Metastatic Cancer

Activated

03-01-1990

Closed

11-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8942

High Dose Etoposide, Cyclophosphamide and Either Fractionated Total Body Irradiation or Carmustine Combined with Autologous Bone Marrow Rescue for Refractory or Relapsed Non-Hodgkin's Lymphoma

Research Committee(s)

Lymphoma

Activated

03-01-1990

Closed

12-15-1994

Closed

Phase

Accrual

60%

Published

SWOG Clinical Trial Number

SWOG-8923

Neo-FAC for Poor Prognosis Stage IV Breast Cancer, A Phase II Pilot Study

Research Committee(s)

Breast Cancer

Activated

02-15-1990

Closed

06-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8921

Trials of Cyclophosphamide, IL-2, DTIC/IL-2, and DTIC/Cisplatin/Tamoxifen in Stage IV Melanoma

Research Committee(s)

Melanoma

Activated

02-15-1990

Closed

09-01-1991

Closed

Phase

Published

SWOG Clinical Trial Number

SWOG-8994 (EST-C-0690) (INT-0086)

Evaluation of Quality of Life in Patients with Stage C Adenocarcinoma of the Prostate Enrolled on SWOG-8794 (INT-0086)

Activated

02-15-1990

Closed

01-01-1997

Closed

Phase

Accrual

63%

Published

SWOG Clinical Trial Number

SWOG-8906

Evaluation of Merbarone in Hepatoma, Phase II

Activated

02-01-1990

Closed

05-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8910

Evaluation of Low Dose Continuous 5-Fluorouracil (5-FU) and Weekly Cis-Platinum (CDDP) in Advanced Adenocarcinoma of the Stomach

Activated

01-15-1990

Closed

08-01-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8842

Dihydroxyazacytidine in Malignant Mesothelioma, Phase II

Research Committee(s)

Sarcoma

Activated

12-15-1989

Closed

11-15-1992

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8943

Evaluation of Merbarone in Advanced Soft-Tissue Sarcomas

Activated

12-15-1989

Closed

07-01-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8894 (INT-0105) (EST-2889)

A Comparison of Bilateral Orchiectomy with or without Flutamide for the Treatment of Patients with Histologically Confirmed Stage D2 Prostate Cancer

Research Committee(s)

Genitourinary Cancer

Activated

12-15-1989

Closed

09-15-1994

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8917

5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot

Activated

12-01-1989

Closed

02-15-1992

Closed

Phase

Accrual

93%

Published

SWOG Clinical Trial Number

SWOG-8903

Phase I Trial of Promace-CytoBOM with GM-CSF for Treatment of Non-Hodgkin's Lymphoma

Research Committee(s)

Lymphoma

Activated

11-15-1989

Closed

11-01-1993

Closed

Phase

Accrual

82%

Published

SWOG Clinical Trial Number

SWOG-8828

A Phase II Trial of Carboplatin (CBDCA) in Relapsed or Refractory Acute Myeloid Leukemia

Activated

11-15-1989

Closed

10-15-1992

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8808

A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Chronic Myeloid Leukemia

Activated

11-15-1989

Closed

11-15-1990

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8857

Alternating Cisplatin/VP-16 with Continuous CAV and Consolidation Chemoradiotherapy for Extensive Small Cell Lung Cancer with PCI for Complete Responders

Activated

10-15-1989

Closed

05-15-1991

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8926

Evaluation of Low Dose Continuous Infusion 5-Fluorouracil in Patients with Advanced and Recurrent Renal Cell Carcinoma

Activated

10-01-1989

Closed

02-15-1991

Closed

Phase

Accrual

SWOG Clinical Trial Number

SWOG-8999

Evaluation of Radiation Treatment Following Surgical Resection of Solitary Brain Metastasis

Activated

08-15-1989

Closed

12-15-1990

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

SWOG-8905

Phase II/III Study of Fluorouracil (5-FU) and its Modulation in Advanced Colorectal Cancer

Activated

08-01-1989

Closed

01-01-1993

Closed

Phase

Accrual

60%

Published

SWOG Clinical Trial Number

SWOG-8912

Evaluation of Fazarabine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck

Activated

07-15-1989

Closed

01-01-1991